Mesalamine Tablet, Delayed Release
Product Images NDC 0904-6832

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0904-6832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

438a8c72 38e5 4d31 A2b0 418c6366ecbd 01

438a8c72 38e5 4d31 A2b0 418c6366ecbd 01
Chemical structure of mesalamine, showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*
FDA Label Image

Bea6dfe6 974a 4203 8c5a E02861743fb7 00

Bea6dfe6 974a 4203 8c5a E02861743fb7 00
Label for mesalamine delayed-release tablets, USP 1.2 g by Major Pharmaceuticals. The label states the product is for oral use, prescription only, with a package size of 30 tablets. It includes storage instructions and dispensing information. The NDC number 0904-6832-04 appears along with manufacturer and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.